Nadim Ahmed - 23 Dec 2025 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
President and CEO, Director
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
23 Dec 2025
Net transactions value
-$99,319
Form type
4
Filing time
29 Dec 2025, 17:00:04 UTC
Previous filing
16 Jul 2025
Next filing
19 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AHMED NADIM President and CEO, Director C/O CULLINAN THERAPEUTICS, INC., ONE MAIN STREET, SUITE 1350, CAMBRIDGE /s/ Jacquelyn Sumer, Attorney-in-Fact 29 Dec 2025 0001731193

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale $99,319 -9,922 -2.3% $10.01 420,699 23 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.